Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,595 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia.
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Shiba N, Ohki K, Hayashi Y, Yamashita Y, Shimada A, Tanaka S, Adachi S. Matsuo H, et al. Among authors: fujimoto j. Haematologica. 2014 Nov;99(11):e225-7. doi: 10.3324/haematol.2014.107128. Epub 2014 Jul 11. Haematologica. 2014. PMID: 25015941 Free PMC article. No abstract available.
Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S. Matsuo H, et al. Among authors: fujimoto j. Blood Cancer J. 2014 Jul 11;4(7):e226. doi: 10.1038/bcj.2014.47. Blood Cancer J. 2014. PMID: 25014773 Free PMC article.
Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.
Tokumasu M, Murata C, Shimada A, Ohki K, Hayashi Y, Saito AM, Fujimoto J, Horibe K, Nagao M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Tomizawa D, Taga T, Tawa A, Tanaka S, Heike T, Adachi S. Tokumasu M, et al. Among authors: fujimoto j. Leukemia. 2015 Dec;29(12):2438-41. doi: 10.1038/leu.2015.121. Epub 2015 May 15. Leukemia. 2015. PMID: 25975190 No abstract available.
Prognostic Impact of Intensified Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
Sunami S, Sekimizu M, Takimoto T, Mori T, Mitsui T, Fukano R, Saito AM, Watanabe T, Ohshima K, Fujimoto J, Nakazawa A, Kobayashi R, Horibe K, Tsurusawa M. Sunami S, et al. Among authors: fujimoto j. Pediatr Blood Cancer. 2016 Mar;63(3):451-7. doi: 10.1002/pbc.25824. Epub 2015 Nov 19. Pediatr Blood Cancer. 2016. PMID: 26585702
Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
Fukano R, Sunami S, Sekimizu M, Takimoto T, Mori T, Mitsui T, Mori T, Saito AM, Watanabe T, Ohshima K, Fujimoto J, Nakazawa A, Kiyokawa N, Kobayashi R, Horibe K, Tsurusawa M. Fukano R, et al. Among authors: fujimoto j. J Pediatr Hematol Oncol. 2018 Jan;40(1):e34-e37. doi: 10.1097/MPH.0000000000000850. J Pediatr Hematol Oncol. 2018. PMID: 28538509
Improved treatment results of children with B-cell non-Hodgkin lymphoma: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study.
Tsurusawa M, Mori T, Kikuchi A, Mitsui T, Sunami S, Kobayashi R, Takimoto T, Saito A, Watanabe T, Fujimoto J, Nakazawa A, Ohshima K, Horibe K; lymphoma committee of Japanese Pediatric Leukemia/Lymphoma Study Group. Tsurusawa M, et al. Among authors: fujimoto j. Pediatr Blood Cancer. 2014 Jul;61(7):1215-21. doi: 10.1002/pbc.24975. Epub 2014 Feb 13. Pediatr Blood Cancer. 2014. PMID: 24523211 Clinical Trial.
Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).
Sekimizu M, Mori T, Kikuchi A, Mitsui T, Sunami S, Kobayashi R, Fujita N, Inada H, Takimoto T, Saito AM, Watanabe T, Fujimoto J, Nakazawa A, Ohshima K, Horibe K, Tsurusawa M; Lymphoma Committee of the Japanese Pediatric Leukemia/Lymphoma Study Group. Sekimizu M, et al. Among authors: fujimoto j. Pediatr Blood Cancer. 2015 Jul;62(7):1294-6. doi: 10.1002/pbc.25482. Epub 2015 Mar 19. Pediatr Blood Cancer. 2015. PMID: 25790170
Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma.
Tsurusawa M, Gosho M, Mori T, Mitsui T, Sunami S, Kobayashi R, Fukano R, Tanaka F, Fujita N, Inada H, Koh K, Takimoto T, Saito A, Fujimoto J, Nakazawa A, Horibe K; lymphoma committee of the Japanese Pediatric Leukemia/lymphoma Study Group. Tsurusawa M, et al. Among authors: fujimoto j. Pediatr Blood Cancer. 2015 Feb;62(2):279-284. doi: 10.1002/pbc.25305. Epub 2014 Oct 30. Pediatr Blood Cancer. 2015. PMID: 25359701
1,595 results